Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2026 Earnings Call Transcript February 3, 2026 Operator: Good day, everyone. And ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Four strategies spanning cognitive-behavioral therapy, mindfulness-based therapies, positive psychology and acceptance and ...

Every two years, the world comes together in celebration of the Olympic Games. Established in Greece, the Olympics have been around for thousands of years. While they've evolved over time, one thing ...